CARDIOPROGRESS
Foundation for the advancement of cardiology

Knowledge, observation, action

Сlinical trials

Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction

CARDia: Coronary Artery Revascularisation in Diabetes trial

REVERSE study: CRT produces long-term improvements in disease progression in mildly symptomatic heart failure patients. Five-year results from the REsynchronization reVErses Remodeling in Sys

PRoFESS: Impact of resting heart rates on recurrent stroke, cardiovascular outcomes, disability and cognitive decline in 20.165 patients after ischemic stroke

IABP-SHOCK II: Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated b

DeFACTO: Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography

The Great East Japan Earthquake Disaster and Cardiovascular Diseases

AFib Ablation Pilot: ESC-EURObservational Research Programme: 1-year follow-up of the Atrial Fibrillation Ablation Conducted by the European Heart Rhythm Association

PRAGUE-12: Randomized open multicenter study comparing cardiac surgery with MAZE versus cardiac surgery without MAZE in patients with coronary and/or valvular heart disease and with atrial fi

FAST-MI programme: Decrease in early mortality in STEMI is related to changing patient profile and behavior, as well as improved organization of care: Data from 4 French nationwide surveys ov

Scientific news

CRAVE: No Spike in Atrial Arrhythmias Among Coffee Drinkers A novel trial using real-time monitoring found that drinking coffee did not increase atrial arrhythmias but was associated with more premature ventricular contractions. There was no increase in premature atrial contractions (PACs) or supraventricular tachycardia (SVT) with coffee consumption, and, in fact, there was less SVT in per protocol analyses.

BP Track: Blood Pressure Control Rates Dropped During Pandemic The proportion of hypertensive patients with blood pressure control fell substantially in the United States during the COVID-19 pandemic, if the data from 24 health systems is representative of national trends.

Statins may reduce death from, severity of COVID-19 among those with heart disease or high blood pressure Research published today in The Public Library of Science ONE, PLOS ONE, examined the relationship between use of medications to control cholesterol or blood pressure levels, and the risk of death among people who were hospitalized due to COVID-19.

Death disruptor: how an Australian funnel-web spider may help human hearts A protein in the venom of a deadly Australian funnel-web spider may be able to reduce cardiac damage from heart attacks and extend the life of donor hearts used in transplants, according to new research.

Comorbidities and COVID: A much higher risk of death While some countries are vaccinating their way out of the COVID-19 pandemic and are starting to see an easing of restrictions, other countries in South Asia are experiencing a new wave of infections that are causing devastation to their populations and healthcare systems.

Partners

Video resource

Channel "Cardioprogress"

Follow us